DFX Intelligence
Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Transactions / S••••
CapVest Completes Majority Acquisition of S••••
Platform acquisitionclosedannounced Mar 29, 2026closed Mar 29, 2026Fact
What happened
- Target
- S••••
- Platform
- not an add-on on record
- Control
- Control
- Share acquired
- unknown
- Industry
- unknown
- Target location
- unknown
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
4 named
Buy side
- “M••• F•••••, Partner at CapVest, said: “While we have worked to complete this transaction, the STADA team has continued to demonstrate strong growth across key regions and consumer healthcare, generics, biosimilars and innovative medicines.”
- “Bad Vilbel, Germany and London, United Kingdom: C•••••• P••••••• L•• (“CapVest”), a leading global investment firm, today announces the completion of its acquisition of the majority stake in STADA Arzneimittel AG (“STADA” or the “Company”), a leading healthcare and pharmaceuticals company specializi”
Side not stated
- “P•••• G•••••••••, Chief Executive Officer of STADA, commented: “We are delighted the transaction has now completed.”
- “CapVest Completes Majority Acquisition of S••••”
Evidence
“CapVest Completes Majority Acquisition of S••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026